Screening for prostate cancer: A Cochrane systematic review

[11] Semmens J(1999)Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial Prostate 38 83-91

[12] Rouse I(2004)Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial Prostate 59 311-318

[13] Bass A(2004)Clinical consequences of screening for prostate cancer 15 years follow-up of a randomised controlled trial in Sweden Clinical consequences of screening for prostate cancer 15 years follow-up of a randomised controlled trial in Sweden 46 717-724

[14] Ferrini R(2005)Rotterdam randomized pilot studies of screening for prostate cancer—an overview after 10 years J Natl Cancer Inst 97 696-184

[15] Woolf S(2002)Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries BJU Int 90 174-43

[16] Coley C(2006)The effectiveness of screening for prostate cancer. A nested case-control study Arch Intern Med 166 38-1529

[17] Barry M(1991)Case-control study of screening for prostatic cancer by digital rectal examinations Lancet 337 1526-179

[18] Mulley A(1998)Screening digital rectal examination and prostate cancer mortality: a population based case-control study Urology 52 173-499

[19] Harris R(2005)Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study J Urol 174 495-466

[20] Lohr K(2001)The value of current diagnostic tests in prostate cancer screening BJU Int 88 458-9

[11] Semmens J(1999)Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial Prostate 38 83-91

[12] Rouse I(2004)Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial Prostate 59 311-318

[13] Bass A(2004)Clinical consequences of screening for prostate cancer 15 years follow-up of a randomised controlled trial in Sweden Clinical consequences of screening for prostate cancer 15 years follow-up of a randomised controlled trial in Sweden 46 717-724

[14] Ferrini R(2005)Rotterdam randomized pilot studies of screening for prostate cancer—an overview after 10 years J Natl Cancer Inst 97 696-184

[15] Woolf S(2002)Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries BJU Int 90 174-43

[16] Coley C(2006)The effectiveness of screening for prostate cancer. A nested case-control study Arch Intern Med 166 38-1529

[17] Barry M(1991)Case-control study of screening for prostatic cancer by digital rectal examinations Lancet 337 1526-179

[18] Mulley A(1998)Screening digital rectal examination and prostate cancer mortality: a population based case-control study Urology 52 173-499

[19] Harris R(2005)Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study J Urol 174 495-466

[20] Lohr K(2001)The value of current diagnostic tests in prostate cancer screening BJU Int 88 458-9